Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
- G. Hebenstreit, K. Fellerer, +7 authors W. Soukop
- Psychology, Medicine
- Pharmacopsychiatry
- 1 July 1989
Rolipram improves signal transmission in central noradrenergic neurones at a pre- and postsynaptic level, and is thus a novel approach in antidepressant therapy. In order to prove efficacy,… Expand
Neurochemical perspectives to the function of monoamine oxidase
- P. Riederer, C. Konradi, G. Hebenstreit, M. B. Youdim
- Chemistry, Medicine
- Acta neurologica Scandinavica. Supplementum
- 1 November 1989
Abstract– Dopamine (DA) is degradated in part by MAO, an intraneuronal and glial enzyme localized at the outer mitochondrial membrane. DA is a good substrate for MAO‐B and selegiline enhances… Expand
Susceptibility of Brains from Patients with Alzheimer's Disease to Oxygen-Stimulated Lipid Peroxidation and Differential Scanning Calorimetry
- M. Goetz, A. Freyberger, +9 authors P. Riederer
- Psychology
- 1992
The formation of thiobarbituric-acid-reactive substances (TBARS) indicative of oxygen-induced lipid peroxidation in vitro was assayed in the frontal cortex, hippocampus, putamen, basal nucleus of Meyn
[Treatment of hypotension caused by psychopharmacological drugs (author's transl)].
- G. Hebenstreit
- Medicine
- Wiener medizinische Wochenschrift
- 28 February 1981
By monitoring the clinical symptoms and several cardiovascular parameters in patients treated with psychopharmacological agents the effect of the peripheric alpha-sympathomimetic drug midodrine was… Expand
Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease
- H. Reichmann, Stephanie Fhirke, G. Hebenstreit, Hans Schrubar, P. Riederer
- Biology, Medicine
- Journal of Neurology
- 1 June 1993
Biochemical and mitochondrial DNA analyses were performed in post-mortem brain tissue from seven patients with dementia of Alzheimer's type and age- and sex-matched controls. We analysed all… Expand
The Role of Dopamine in the Control of Neurobiological Functions
- P. Riederer, E. Sofic, +5 authors G. Hebenstreit
- Biology
- 1989
It is only 30 years since dopamine (DA) was first measured in human brain tissue by Sano [98] (Fig.1). One year later Ehringer and Hornykiewicz [34] demonstrated a striatal DA deficiency in… Expand
Senile dementia of Alzheimer’s type and Parkinson’s disease: neurochemical overlaps and specific differences
- P. Riederer, E. Sofic, +6 authors M. Youdim
- Psychology
- 1990
Parkinson’s disease (PD) is characterized by a clear rank order with respect to neuropathological findings. Both substantia nigra (SN) and locus coeruleus (LC) are severely damaged, whilst nucleus… Expand
The Role of Brain Dopamine
- P. Riederer, E. Sofic, +10 authors T. Petcher
- Chemistry
- Basic and Clinical Aspects of Neuroscience
- 1989
The Role of Dopamine in the Control of Neurobiological Functions.- Parkinson's Disease.- Morphological Basis for the Pathobiochemistry of the Nigrostriatal Dopamine Systems.- Pathobiochemistry of… Expand
A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
- G. Hebenstreit, G. Laux, +7 authors W. T. Kanzow
- Psychology, Medicine
- Pharmacopsychiatry
- 1 September 1991
A double-blind multicentre study comparing the efficacy and safety of remoxipride in controlled-release formulation (REM-CR), given once a day, and immediate-release formulation (REM-IR) and… Expand
Biochemical Membrane Constituents and Activities of Alkaline and Acid Phosphatase and Cathepsin in Cortical and Subcortical Brain Areas in Dementia of the Alzheimer Type
- E. Sofic, L. Froelich, +7 authors G. Ransmayr
- Biology
- 1991
Biochemical substrates and activities of three enzymes were determined in cortical and subcortical brain areas from neuropathologically proven cases with dementia of the Alzheimer type (DAT) and age-m